These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Use of desferrioxamine in the treatment of aceruloplasminemia. Miyajima H, Takahashi Y, Kamata T, Shimizu H, Sakai N, Gitlin JD. Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364 [Abstract] [Full Text] [Related]
5. Aceruloplasminemia, an inherited disorder of iron metabolism. Miyajima H, Takahashi Y, Kono S. Biometals; 2003 Mar; 16(1):205-13. PubMed ID: 12572680 [Abstract] [Full Text] [Related]
6. Glucose and oxygen hypometabolism in aceruloplasminemia brains. Miyajima H, Takahashi Y, Kono S, Sugimoto M, Suzuki Y, Hishida A, Sakamoto M, Ouchi Y. Intern Med; 2002 Mar; 41(3):186-90. PubMed ID: 11929178 [Abstract] [Full Text] [Related]
8. Aceruloplasminemia, an iron metabolic disorder. Miyajima H. Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552 [Abstract] [Full Text] [Related]
9. Aceruloplasminemia: an update. Kono S. Int Rev Neurobiol; 2013 Dec; 110():125-51. PubMed ID: 24209437 [Abstract] [Full Text] [Related]
10. Extensive brain pathology in a patient with aceruloplasminemia with a prolonged duration of illness. Kaneko K, Hineno A, Yoshida K, Ohara S, Morita H, Ikeda S. Hum Pathol; 2012 Mar; 43(3):451-6. PubMed ID: 21889188 [Abstract] [Full Text] [Related]
11. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia. Miyajima H, Adachi J, Tatsuno Y, Takahashi Y, Fujimoto M, Kaneko E, Gitlin JD. Neurology; 1998 Jan; 50(1):130-6. PubMed ID: 9443469 [Abstract] [Full Text] [Related]
12. CSF abnormalities in patients with aceruloplasminemia. Miyajima H, Fujimoto M, Kohno S, Kaneko E, Gitlin JD. Neurology; 1998 Oct; 51(4):1188-90. PubMed ID: 9781556 [Abstract] [Full Text] [Related]
13. Aceruloplasminemia. Kono S. Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740 [Abstract] [Full Text] [Related]
14. Molecular and pathological basis of aceruloplasminemia. Kono S, Miyajima H. Biol Res; 2006 Aug; 39(1):15-23. PubMed ID: 16629161 [Abstract] [Full Text] [Related]
15. Redox active iron accumulation in aceruloplasminemia. Gonzalez-Cuyar LF, Perry G, Miyajima H, Atwood CS, Riveros-Angel M, Lyons PF, Siedlak SL, Smith MA, Castellani RJ. Neuropathology; 2008 Oct; 28(5):466-71. PubMed ID: 18282164 [Abstract] [Full Text] [Related]
16. Defective electron transfer in complexes I and IV in patients with aceruloplasminemia. Kohno S, Miyajima H, Takahashi Y, Suzuki H, Hishida A. J Neurol Sci; 2000 Dec 15; 182(1):57-60. PubMed ID: 11102640 [Abstract] [Full Text] [Related]
17. Teaching NeuroImages: neurodegeneration with brain iron accumulation in aceruloplasminemia. Parks NE, Vandorpe RA, Moeller JJ. Neurology; 2013 Nov 12; 81(20):e151-2. PubMed ID: 24218322 [Abstract] [Full Text] [Related]
18. Treatment of symptomatic heterozygous aceruloplasminemia with oral zinc sulphate. Kuhn J, Bewermeyer H, Miyajima H, Takahashi Y, Kuhn KF, Hoogenraad TU. Brain Dev; 2007 Aug 12; 29(7):450-3. PubMed ID: 17307325 [Abstract] [Full Text] [Related]
19. Iron overload and antioxidative role of perivascular astrocytes in aceruloplasminemia. Oide T, Yoshida K, Kaneko K, Ohta M, Arima K. Neuropathol Appl Neurobiol; 2006 Apr 12; 32(2):170-6. PubMed ID: 16599945 [Abstract] [Full Text] [Related]
20. Role of iron in neurodegenerative disorders. Berg D, Youdim MB. Top Magn Reson Imaging; 2006 Feb 12; 17(1):5-17. PubMed ID: 17179893 [Abstract] [Full Text] [Related] Page: [Next] [New Search]